These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 115017)

  • 1. Adverse central effects of drugs in man: predictive value of behavioral studies in rodents and primates.
    Brimblecombe RW; Nicholson AN; Wright CM
    Pharmacol Ther B; 1979; 5(1-3):455-60. PubMed ID: 115017
    [No Abstract]   [Full Text] [Related]  

  • 2. 5-Methoxy-N,N-dimethyltryptamine: behavioral and toxicological effects in animals.
    Gillin JC; Tinklenberg J; Stoff DM; Stillman R; Shortlidge JS; Wyatt RJ
    Biol Psychiatry; 1976 Jun; 11(3):355-8. PubMed ID: 820383
    [No Abstract]   [Full Text] [Related]  

  • 3. Behavioral tests in acute and chronic toxicity studies.
    Brimblecombe RW
    Pharmacol Ther B; 1979; 5(1-3):413-5. PubMed ID: 493322
    [No Abstract]   [Full Text] [Related]  

  • 4. Behavioural activity in the monkey (Macaca mulatta) of the metabolites of diazepam in man [proceedings].
    Nicholson AN; Wright CM
    Br J Pharmacol; 1976 Jul; 57(3):429P. PubMed ID: 823999
    [No Abstract]   [Full Text] [Related]  

  • 5. Is behavior or morphology a more sensitive indicator of central nervous system toxicity?
    Norton S
    Environ Health Perspect; 1978 Oct; 26():21-7. PubMed ID: 363417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Actions of some toxic substances (psychotomimetics) on the central nervous system.
    Bebbington A; Brimblecombe RW
    Br Med Bull; 1969 Sep; 25(3):293-8. PubMed ID: 5812106
    [No Abstract]   [Full Text] [Related]  

  • 7. A behavioral and autonomic nervous system study of RO-5-3350 and diazepam in conscious dogs.
    Korol B; Brown ML
    Pharmacology; 1968; 1(2):115-28. PubMed ID: 5673039
    [No Abstract]   [Full Text] [Related]  

  • 8. 6-hydroxylated N,N-dimethyltryptamines and hallucinogenic potency.
    Uyeno ET
    Proc West Pharmacol Soc; 1969; 12():118-23. PubMed ID: 4980529
    [No Abstract]   [Full Text] [Related]  

  • 9. Assessing the predictive value of the rodent neurofunctional assessment for commonly reported adverse events in phase I clinical trials.
    Mead AN; Amouzadeh HR; Chapman K; Ewart L; Giarola A; Jackson SJ; Jarvis P; Jordaan P; Redfern W; Traebert M; Valentin JP; Vargas HM
    Regul Toxicol Pharmacol; 2016 Oct; 80():348-57. PubMed ID: 27155597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological activity of some ring-substituted tryptamines.
    Hunt RR; Brimblecombe RW
    J Med Chem; 1967 Jul; 10(4):646-8. PubMed ID: 4962512
    [No Abstract]   [Full Text] [Related]  

  • 11. The hallucinogenic world of tryptamines: an updated review.
    Araújo AM; Carvalho F; Bastos Mde L; Guedes de Pinho P; Carvalho M
    Arch Toxicol; 2015 Aug; 89(8):1151-73. PubMed ID: 25877327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioral effects of N,N-dimethyltryptamine in rats and mice.
    Moussatché H; Carlini EA; dos Santos M
    Rev Bras Biol; 1970 Dec; 30(4):483-9. PubMed ID: 5535408
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of reserpine, para-chlorophenylalanine, 5,6-dihydroxytryptamine and fludiazepam on the head twitches induced by 5-hydroxytryptamine or 5-methoxytryptamine in mice.
    Nakamura M; Fukushima H
    J Pharm Pharmacol; 1978 Apr; 30(4):254-6. PubMed ID: 24719
    [No Abstract]   [Full Text] [Related]  

  • 14. Black marks for MBK.
    Cooper P
    Food Cosmet Toxicol; 1979 Dec; 17(6):682-3. PubMed ID: 232685
    [No Abstract]   [Full Text] [Related]  

  • 15. [Possibilities of detecting and differentiating central nervous effects of drugs in animal experiments with special consideration of behavioral-pharmacologic methods].
    Hoffmeister F; Wuttke W
    Arzneimittelforschung; 1975 Jul; 25(7a):1162-78. PubMed ID: 241358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a Functional Observational Battery in the Minipig for Regulatory Neurotoxicity Assessments.
    Zhong M; Shoemake C; Fuller A; White D; Hanks C; Brocksmith D; Liu J; Gad S; Bouchard G; Stricker-Krongrad A
    Int J Toxicol; 2017; 36(2):113-123. PubMed ID: 28196426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative behavioral effects of several anticholinergic agents in rats.
    Pradhan SN; Roth T
    Psychopharmacologia; 1968; 12(4):358-66. PubMed ID: 5652217
    [No Abstract]   [Full Text] [Related]  

  • 18. CNS safety pharmacology: A focus on cognitive functions.
    Hernier AM; Froger-Colléaux C; Castagné V
    J Pharmacol Toxicol Methods; 2016; 81():286-94. PubMed ID: 27071953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-MeO-DALT; a novel designer drug on the market causing acute delirium and rhabdomyolysis.
    Kalasho A; Vibe Nielsen S
    Acta Anaesthesiol Scand; 2016 Oct; 60(9):1332-6. PubMed ID: 27453155
    [No Abstract]   [Full Text] [Related]  

  • 20. Activity of fosazepam, a soluble analogue of diazepam.
    Nicholson AN; Wright CM
    Br J Clin Pharmacol; 1977 Aug; 4(4):494-6. PubMed ID: 409424
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.